Isolation and study of an anthrax protective antigen. V. the dynamics of immunity in vaccination with a concentrated, purified sorbed chemical anthrax vaccine
Sadoyoĭ, N.V.; Derbin, M.I.; Garin, N.S.; Tarumov, V.S.; Mikhaĭlov, V.V.
Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 64-67
1979
ISSN/ISBN: 0372-9311 PMID: 110017 Document Number: 151209
Document emailed within 1 workday
Related Documents
Kaufmann, A.F.; Fox, M.D.; Kolb, R.C. 1973: Anthrax in Louisiana, 1971: an evaluation of the Sterne strain anthrax vaccine Journal of the American Veterinary Medical Association 163(5): 442-445Cymet, T.C.; Kerkvliet, G.J. 2002: Follow-up on "Symptoms associated with anthrax exposure: suspected 'aborted' anthrax" Journal of the American Osteopathic Association 102(4): 203
Abalakin, V.A.; Cherkasskiĭ, B.L. 1986: Hereditary resistance to anthrax and sensitivity to the anthrax toxin in mice Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 45-49
Meldrum, K.C. 1989: Anthrax vaccination Veterinary Record 125(2): 48-49
Beyer, W. 2004: Vaccination strategies for anthrax prevention Berliner und Munchener Tierarztliche Wochenschrift 117(11-12): 508-524
Kournikakis, B.; Mandeville, R.; Brousseau, P.; Ostroff, G. 2003: Anthrax-protective effects of yeast beta 1,3 glucans Medgenmed: Medscape General Medicine 5(1): 1
Romanov, G.I. 1980: Preparation, control and application of anthrax vaccine in USSR Archiv für Experimentelle Veterinarmedizin 34(1): 119-122
Siegel-Itzkovich, J. 2009: IDF's anthrax vaccine trial "violated Helsinki Convention" Bmj 338: B1325
James, S.L. 1985: Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine is dependent on the method of antigen presentation Journal of Immunology 134(3): 1956-1960
2002: From the Centers for Disease Control. Status of US Department of Defense preliminary evaluation of the association of anthrax vaccination and congenital anomalies JAMA 287(9): 1107
Gilson, R.T.; Schissel, D.J. 2004: Recurrent, localized urticaria and erythema multiforme: a review and management of cutaneous anthrax vaccine-related events Cutis 73(5): 319-325
Selimov, M.A.; El'bert, L.B.; Aksenova, T.A.; Kliueva, E.V.; Gribencha, L.F. 1977: Antigenic activity of a concentrated and purified cultured antirabies vaccine from the Vnukovo-32-107 strain Voprosy Virusologii 5: 581-585
Süliová, J.; Benísek, Z.; Svrcek, S.; Durove, A.; Ondrejka, R. 1997: The effectiveness of inactivated, purified and concentrated experimental rabies vaccine for veterinary use: immunogenic activity Veterinarni Medicina 42(2): 51-56
Chakraborty, P.P.; Thakurt, S.G.; Satpathi, P.S.; Hansda, S.; Sit, S.; Achar, A.; Banerjee, D. 2012: Outbreak of cutaneous anthrax in a tribal village: a clinico-epidemiological study Journal of the Association of Physicians of India 60: 89-93
Muntiu, N.; Dumitrescu, A.; Dohotaru, V.; Negrutiu, T.; Bercan, A.; Mircescu, G.; Stirbu, C.; Tomescu, A. 1972: Duration of post-vaccination immunity against foot-and-mouth disease in relation to animal age, vaccine dose and vaccination repetition (recurrence effect) Bulletin - Office International des Epizooties 77(5): 771-787
Gubenko, T.L.; Iarots'ka, N.E.; Ribakova, T.M.; Lichkovs'ka, E.V.; Stepula, V.V.; Sharapova, O.K.; Nedostup, F.I. 1972: Use of concentrated and purified enterovirus antigens for the study of the etiology of neuroviral diseases Mikrobiolohichnyi Zhurnal 34(1): 51-52
Popov, O.V. 1983: Correlation between the frequency of the occurrence of temperature reactions and humoral immunity indices in persons inoculated with a concentrated tick-borne encephalitis vaccine Voprosy Virusologii 2: 244-245
Bhatt, K.M.; Bhatt, S.M. 2002: Anthrax revisited East African Medical Journal 79(7): 364-367
Arrese, J.E.; Piérard-Franchimont, C.; Piérard, G.E. 2001: Anthrax and carbuncle Revue Medicale de Liege 56(10): 685-688
Drake, D.J.; Blair, A.W. 1971: Meningitic anthrax Central African Journal of Medicine 17(5): 97-98